Case reports and Epidemiology
A case report is usually considered a kind of circumstantial proof. Given their intrinsic method limitations, including the absence of statistical sampling, case reports are placed at the foot of the hierarchy of clinical proof, beside case series. However, Hematology case reports do have unaffectedly helpful roles in medical research and evidence-based drugs. Specifically, they need abridged recognition of recent diseases and adverse effects of treatments. For instance, recognition of the link between administration of teratogen to mothers and malformations in their babies was suggested by the report of a specific case. Case reports have a task in pharmacovigilance. They will additionally facilitate understand the clinical spectrum of rare diseases or moreover as uncommon presentations of common diseases. They can facilitate and generate study of hypotheses, as well as conceivable mechanisms of disease. Case reports might also have given a task to play in guiding the personalization of treatments in clinical follow.
Related Conference of Case reports and Epidemiology
Case reports and Epidemiology Conference Speakers
Recommended Sessions
- Advanced Treatment And Research In Hematology
- Biomarkers in Hematology and Oncology
- Blood Disorders
- Blood Disorders, Symptom and Treatment
- Bone Marrow Transplantation
- Case reports and Epidemiology
- Cervical Cancer
- Clinical Hematology
- Effect of Advanced Technologies on Blood Based Products
- Hematologic abnormalities
- Hematology and Hematologist
- Hematology Disorders
- Hematology Nursing
- Hematology Oncology
- Leukemia and Blood Cancer
- Pediatric Hematology
- Stem Cell Therapy
- Stem Cell Therapy
- Transfusion medicine
- Veterinary Hematology
Related Journals
Are you interested in
- Bleeding Disorders in Women - Blood Disorders 2024 (Ireland)
- Digital Health and Artificial Intelligence (AI) in Hematology - Blood Disorders 2024 (Ireland)
- Hematologic Gene Editing and Gene Therapies - Blood Disorders 2024 (Ireland)
- Hematology and Stem Cell Research - Blood Disorders 2024 (Ireland)
- Hematopoietic Stem Cell Transplantation - Blood Disorders 2024 (Ireland)
- Hemoglobinopathies and Sickle Cell Disease - Blood Disorders 2024 (Ireland)
- Hemophilia Management and Research - Blood Disorders 2024 (Ireland)
- Hemostasis and Thrombosis - Blood Disorders 2024 (Ireland)
- Immunotherapy and Hematology - Blood Disorders 2024 (Ireland)
- Leukemia and Lymphoma - Blood Disorders 2024 (Ireland)
- Medicine in Hematology - Blood Disorders 2024 (Ireland)
- Molecular Hematology - Blood Disorders 2024 (Ireland)
- Myelodysplastic Syndromes (MDS) and Bone Marrow Failure - Blood Disorders 2024 (Ireland)
- Next-Generation Diagnostics and Imaging - Blood Disorders 2024 (Ireland)
- Novel Therapies for Blood Cancers - Blood Disorders 2024 (Ireland)
- Pediatric Hematology - Blood Disorders 2024 (Ireland)
- Platelet Disorders - Blood Disorders 2024 (Ireland)
- Sickle Cell Disease (SCD) - Blood Disorders 2024 (Ireland)
- Thalassemia Management - Blood Disorders 2024 (Ireland)
- Transfusion Medicine and Blood Banking - Blood Disorders 2024 (Ireland)